Once your drug or therapy is approved and launched, our specialist translation services will support you through pharmacovigilance, regulatory submissions, and global compliance.
Clinical trials can only take a drug so far. Even the most diverse trial can’t test for everything, like the effects of extended use or the possibility of rare adverse events. At Conversis, an IQVIA business, we translate critical safety and regulatory documentation, helping you meet regional requirements and communicate clearly with regulators and healthcare professionals.
We combine decades of life sciences expertise, AI-enabled workflows, and a global network of subject-matter expert linguists to help you process large volumes of post-market data quickly and accurately. Our expertise ensures your post-market documentation remains compliant and ready for submission in every market and to global regulatory authorities, including the EMA, FDA, and MHRA.
